HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy and safety of total glucosides of peony in the treatment of primary Sjögren's syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial.

Abstract
To evaluate the efficacy and safety of total glucosides of peony (TGP) in adults with primary Sjögren's syndrome (pSS). A multi-center, randomized, double-blinded, placebo-controlled study was conducted between March 2012 and July 2014 at ten Chinese hospitals. In total, 320 pSS patients-classified according to the 2002 American-European Consensus Group Criteria-were randomized (2:1 ratio) to receive TGP(600 mg, tid) in the TGP group or placebo for 24 weeks in the placebo group. Study personnel, investigators, and patients were blinded to the treatment grouping. The primary endpoint was the improvement of EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) at week 24. The secondary endpoints were dry eyes/mouth/skin/nose/throat/vagina visual analogue scale (VAS), pain and discomfort VAS, fatigue VAS, mental discomfort VAS, patient global assessment (PGA), EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI), Schirmer's test, basal/stimulated salivary flow-rate values, and erythrocyte sedimentation rate (ESR). All adverse events were recorded during the trial period. ESSPRI improved more in the TGP than the placebo group (p < 0.001). Dry eyes/throat/vagina VAS, fatigue VAS, mental discomfort VAS, PGA, Schirmer's test, and ESR also improved more in the TGP group than in the placebo group (all p < 0.05). Stimulated salivary flow-rate values increased in the TGP group at week 12 but not at week 24. Adverse events in TGP group were 10.9%. TGP can alleviate some dryness symptoms as well as disease activity in pSS patients over 24 weeks. TGP was well tolerated by study subjects. TGP seems to be an effective and safe treatment for pSS.
AuthorsXia Liu, Xiaomei Li, Xiangpei Li, Zhijun Li, Dongbao Zhao, Shengyun Liu, Miaojia Zhang, Fengxiao Zhang, Ping Zhu, Jinwei Chen, Wei Wei, Bing Lin, Yingbo Zhou, Jing Chen, Yafei Pang, Lei Zhang, Xiaoxuan Sun, Zhibo Yu, Yun Jia, Jia Wang, Wenwen Sun, Frank Chiu, Liping Pang, Guochun Wang
JournalClinical rheumatology (Clin Rheumatol) Vol. 38 Issue 3 Pg. 657-664 (Mar 2019) ISSN: 1434-9949 [Electronic] Germany
PMID30280368 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Plant Extracts
Topics
  • Adult
  • Diarrhea (chemically induced)
  • Double-Blind Method
  • Fatigue
  • Female
  • Humans
  • Male
  • Middle Aged
  • Paeonia
  • Pain Measurement
  • Phytotherapy
  • Plant Extracts (therapeutic use)
  • Plant Roots
  • Salivary Elimination
  • Severity of Illness Index
  • Sjogren's Syndrome (drug therapy, physiopathology)
  • Treatment Outcome
  • Visual Analog Scale

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: